Eosinophilic Asthma Latest Advances

Find the Latest Research About Eosinophilic Asthma

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1691 publications

Sensitization to aeroallergens and asthma severity in the tropics.

Sensitization to aeroallergens and asthma severity in the tropics.

Journal: European annals of allergy and clinical immunology
Published: March 20, 2026

Efficacy and safety of biologics in children and adolescents with eosinophilic asthma: A systematic review and meta-Analysis.

Efficacy and safety of biologics in children and adolescents with eosinophilic asthma: A systematic review and meta-Analysis.

Journal: Asian Pacific journal of allergy and immunology
Published: March 15, 2026

Baseline dual elevation of fractional exhaled nitric oxide and blood eosinophils is associated with clinical remission in severe eosinophilic asthma treated with biologics: a real-world prospective study.

Baseline dual elevation of fractional exhaled nitric oxide and blood eosinophils is associated with clinical remission in severe eosinophilic asthma treated with biologics: a real-world prospective study.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: March 14, 2026

Depemokimab (Exdensur) for severe eosinophilic asthma.

Depemokimab (Exdensur) for severe eosinophilic asthma.

Journal: The Medical letter on drugs and therapeutics
Published: March 07, 2026

Systemic coagulation and fibrinolytic alterations in eosinophilic asthma with and without nasal polyps.

Systemic coagulation and fibrinolytic alterations in eosinophilic asthma with and without nasal polyps.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: January 27, 2026

Depemokimab and the twice-yearly regimen: pharmacological implications and therapeutic positioning in severe eosinophilic respiratory diseases.

Depemokimab and the twice-yearly regimen: pharmacological implications and therapeutic positioning in severe eosinophilic respiratory diseases.

Journal: Frontiers in immunology
Published: January 08, 2026

Predictive Factors And Treatments Associated with Clinical Remission in Severe Eosinophilic Asthma.

Predictive Factors And Treatments Associated with Clinical Remission in Severe Eosinophilic Asthma.

Journal: Journal of inflammation research
Published: January 07, 2026

Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Journal: Biomedicines
Published: December 31, 2025

Real-world clinical experience with benralizumab for severe eosinophilic asthma in the Czech Republic: fewer corticosteroids and better symptom control.

Real-world clinical experience with benralizumab for severe eosinophilic asthma in the Czech Republic: fewer corticosteroids and better symptom control.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: December 27, 2025

Concentration-dependent effects of tobacco smoke on airway inflammation and remodeling in asthmatic models.

Concentration-dependent effects of tobacco smoke on airway inflammation and remodeling in asthmatic models.

Journal: Frontiers in immunology
Published: December 25, 2025

D-Mannose-Modified M2 Macrophage Membrane-Derived Decoy Nanovesicles for Synergistic Immunotherapy of Asthma.

D-Mannose-Modified M2 Macrophage Membrane-Derived Decoy Nanovesicles for Synergistic Immunotherapy of Asthma.

Journal: ACS nano
Published: December 24, 2025

IL-33 Modulates Cytotoxic NK Cell Subsets in Severe Eosinophilic Asthma.

IL-33 Modulates Cytotoxic NK Cell Subsets in Severe Eosinophilic Asthma.

Journal: Life (Basel, Switzerland)
Published: December 19, 2025
Showing 1-12 of 1,691

Last Updated: 04/28/2026